Synapse

← Matthias Egger

Papers by Matthias Egger

Page 1 · newest first

  1. Gender and disciplinary differences in grant proposal peer review: Content and sentiment in 39,280 reportsPLoS ONE · 2026
  2. A framework for collating and synthesizing evidence from human and animal studies: the GALENOS approachBMC Medicine · 2026
  3. Epidemiology and Clinical Impact of Clonal Hematopoiesis in People With HIVThe Journal of Infectious Diseases · 2026
  4. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet · 2007
  5. Reducing spatial clustering to prevent tuberculosis transmission in a busy Zambian hospital: a modelling study based on person movements, environmental and clinical data2025
  6. The relative contribution of close-proximity contacts, shared classroom exposure and indoor air quality to respiratory virus transmission in schoolsNature Communications · 2025
  7. The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling studyThe Lancet Global Health · 2025
  8. Immunodeficiency, HIV Viremia, and Incident Anal Cancer Among People With HIV in South AfricaOpen Forum Infectious Diseases · 2025
  9. Novel integrase mutations linked to genotypic DTG resistance in non-B HIV-1 strains from African participants: The DTG RESIST study2025
  10. Absences, Symptoms and Respiratory Viruses in a Swiss School: Longitudinal Study With Serial Saliva SamplingInfluenza and Other Respiratory Viruses · 2025
  11. Incidence and prognostic factors of self-harm and subsequent unnatural death in South Africa: A cohort studyPLoS Medicine · 2025
  12. Transparent Reporting of Observational Studies Emulating a Target Trial—The TARGET StatementJAMA · 2025
  13. Transparent reporting of observational studies emulating a target trial: the TARGET Statement.2025
  14. Anal cancer incidence rates among men and women with and without HIV in South AfricaOpen Forum Infectious Diseases · 2025
  15. A Supervised Machine Learning Approach for Assessing Grant Peer Review ReportsQuantitative Science Studies · 2025
  16. The relative contribution of close-proximity contacts, shared classroom exposure and indoor air quality to respiratory virus transmission in schools.2025
  17. Mental, physical, and respiratory health in people with tuberculosis in Southern Africa: a multi-country cohort analysisBMC Medicine · 2025
  18. Life‐years lost associated with mental disorders in people with HIV: a cohort study in South Africa, Canada and the United StatesJournal of the International AIDS Society · 2025
  19. Is suicide risk 100‐fold higher in people with HIV? A critical appraisal of a meta‐analysisGeneral Psychiatry · 2025
  20. Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST StudyClinical Infectious Diseases · 2025
  21. Measuring the Performance of Survival Models to Personalize Treatment ChoicesStatistics in Medicine · 2025
  22. Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling studyThe Lancet Global Health · 2025
  23. Estimating Mycobacterium tuberculosis transmission in a South African clinic: Spatiotemporal model based on person movementsPLoS Computational Biology · 2025
  24. Patterns of incident Burkitt lymphoma during the HIV epidemic among the Black African and White population in South AfricaBritish Journal of Cancer · 2025
  25. Late Re-Engagement Into HIV Care Among Adults in the Swiss HIV Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes · 2025
  26. Diagnosis of postpartum depression and associated factors in South Africa: a cohort study of 47,697 womenEpidemiology and Psychiatric Sciences · 2025
  27. HIV-1 Viremia and Cancer Risk in 2.8 Million People: The South African HIV Cancer Match StudyClinical Infectious Diseases · 2024
  28. The effect of combining antibiotics on resistance: A systematic review and meta-analysiseLife · 2024
  29. Cardiovascular Involvement in Tuberculosis Patients Treated in Southern AfricaJACC Advances · 2024
  30. Sociodemographic and regional differences in neonatal and infant mortality in Switzerland in 2011–2018: the Swiss National CohortSwiss Medical Weekly · 2024
  31. HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983–2015PLoS ONE · 2024
  32. The Contribution of Noncommunicable and Infectious Diseases to the Effect of Depression on Mortality: A Longitudinal Causal Mediation AnalysisEpidemiology · 2024
  33. The effect of combining antibiotics on resistance: A systematic review and meta-analysiseLife · 2024
  34. Developing clinical prediction models: a step-by-step guideBMJ · 2024
  35. Courier delivery of antiretroviral therapy: a cohort study of a South African private‐sector HIV programmeJournal of the International AIDS Society · 2024
  36. Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular RiskOpen Forum Infectious Diseases · 2024
  37. Conceptual Design of Shunting Automation Elements Utilising the Digital Automatic Coupler2024
  38. HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST)BMJ Open · 2024
  39. Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  40. Table S6 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  41. Table 3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  42. Table 1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  43. Table S8 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  44. Table S5 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  45. Data from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  46. Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  47. Table S6 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  48. Table S4 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  49. Table S11 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024
  50. Table 2 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study2024